Current Areas of Controversy in the Treatment of Patients with Newly Diagnosed Acute Promyelocytic Leukemia

Martin S. Tallman*, Syed A. Abutalib, Ralph M. Meyer

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationEvidence-Based Hematology
PublisherJohn Wiley and Sons
Number of pages7
ISBN (Print)9781405157476
StatePublished - Feb 4 2009


  • Acute promyelocytic leukemia (APL)
  • American Society of Clinical Oncology (ASCO)
  • American Society of Hematology (ASH)
  • Arsenic trioxide treatment in patients with relapsed and refractory APL
  • Maintenance therapy for patients with APL
  • Malignant hematologic disorders
  • Treatment of high-risk APL

ASJC Scopus subject areas

  • Medicine(all)

Cite this